← Back to headlines
Investment Firms Raise Price Targets for Eli Lilly, Visa After Q1 Results
Cantor Fitzgerald and Raymond James have increased their price targets for Eli Lilly and Visa, respectively. These adjustments follow the companies' strong first-quarter earnings calls and solid results.
7 May, 17:26 — 7 May, 17:26
Sources
Showing 1 of 1 sources
